Moreover, the MC system, especially the melanocortin 4 receptor (MC4-R), are currently a promising target system for the development of drugs intended to treat obesity and eating disorders in humans (Hillebrand et al., 2006; Moriya et al., 2006; Laviano et al., 2008; Steinman and DeBoer, 2013; Girardet and Butler, 2014). Here, MC4R is linked to obesity disorder.